Skip to main content

Advertisement

Log in

Imaging of primary pediatric lymphoma of bone

  • Original Article
  • Published:
Pediatric Radiology Aims and scope Submit manuscript

Abstract

Background

Primary pediatric bone lymphoma is a rare form of non-Hodgkin lymphoma. Unlike nodal forms of lymphoma, imaging abnormalities in lymphoma of bone do not resolve rapidly in conjunction with treatment and radiologic findings can remain abnormal for years, making it difficult to evaluate treatment response.

Objective

To evaluate the utility of imaging in assessment of patients with primary pediatric bone lymphoma.

Materials and methods

At our institution between 2004 and 2013, six cases of pathology-proven primary pediatric bone lymphoma were diagnosed. Retrospective chart review was performed to assess imaging utilization. Our data were qualitatively compared with existing literature to construct an algorithm for imaging patients with primary lymphoma of bone.

Results

Imaging evaluation of patients with primary pediatric bone lymphoma was highly variable at our institution. Conventional imaging was routinely used to evaluate response to treatment, despite lack of appreciable osseous change. Imaging in the absence of symptoms did not alter clinical management. Only positron emission tomography CT (PET/CT) proved capable of demonstrating imaging changes from the pretreatment to the post-treatment scans that were consistent with the clinical response to treatment.

Conclusion

Surveillance imaging is likely unnecessary in patients with a known diagnosis of pediatric lymphoma of bone. Pretreatment and post-treatment PET/CT is likely sufficient to assess response. There is little data to support the use of interim and surveillance PET/CT.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lones MA, Perkins SL, Sposto R et al (2002) Non-Hodgkin's lymphoma arising in bone in children and adolescents is associated with an excellent outcome: a Children's Cancer Group report. J Clin Oncol 20:2293–2301

    Article  PubMed  Google Scholar 

  2. Zhao XF, Young KH, Frank D et al (2007) Pediatric primary bone lymphoma-diffuse large B-cell lymphoma: morphologic and immunohistochemical characteristics of 10 cases. Am J Clin Pathol 127:47–54

    Article  PubMed  Google Scholar 

  3. Ramadan KM, Shenkier T, Sehn LH et al (2007) A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency. Ann Oncol 18:129–135

    Article  CAS  PubMed  Google Scholar 

  4. Suryanarayan K, Shuster JJ, Donaldson SS et al (1999) Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol 17:456–459

    CAS  PubMed  Google Scholar 

  5. Borowitz MJ, Wood BL, Devidas M et al (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children's Oncology Group study AALL0232. Blood 126:964–971

    Article  CAS  PubMed  Google Scholar 

  6. Furman WL, Fitch S, Hustu HO et al (1989) Primary lymphoma of bone in children. J Clin Oncol 7:1275–1280

    CAS  PubMed  Google Scholar 

  7. Glotzbecker MP, Kersun LS, Choi JK et al (2006) Primary non-Hodgkin's lymphoma of bone in children. J Bone Joint Surg Am 88:583–594

    Article  PubMed  Google Scholar 

  8. Borst AJ, States LJ, Reilly AF, Rheingold SR et al (2013) Determining response and recurrence in pediatric B-cell lymphomas of the bone. Pediatr Blood Cancer 60:1281–1286

  9. Okada M, Sato N, Ishii K et al (2010) FDG PET/CT versus CT, MR imaging, and 67Ga scintigraphy in the posttherapy evaluation of malignant lymphoma. Radiographics 30:939–957

    Article  PubMed  Google Scholar 

  10. Ferrari C, Minoia C, Asabella AN et al (2014) Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma. Hell J Nucl Med 1:40–49

    Google Scholar 

  11. Moog F, Bangerter M, Diederichs CG et al (1998) Extranodal malignant lymphoma: detection with FDG PET versus CT. Radiology 206:475–481

    Article  CAS  PubMed  Google Scholar 

  12. Cheson BD, Fisher RI, Barrington SF et al (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32:3059–3068

    Article  PubMed  Google Scholar 

  13. Elstrom RL, Leonard JP, Coleman M et al (2008) Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma. Ann Oncol 19:1770–1773

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Moog F, Kotzerke J, Reske SN (1999) FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407–1413

    CAS  PubMed  Google Scholar 

  15. Quarles van Ufford H, Hoekstra O, de Haas M et al (2010) On the added value of baseline FDG-PET in malignant lymphoma. Mol Imaging Biol 12:225–232

    Article  PubMed  Google Scholar 

  16. Herrmann K, Queiroz M, Huellner MW et al (2015) Diagnostic performance of FDG-PET/MRI and WB-DW-MRI in the evaluation of lymphoma: a prospective comparison to standard FDG-PET/CT. BMC Cancer 15:1002

    Article  PubMed  PubMed Central  Google Scholar 

  17. Yoo HJ, Lee JS, Lee JM (2015) Integrated whole body MR/PET: where are we? Korean J Radiol 16:32–49

    Article  PubMed  PubMed Central  Google Scholar 

  18. Pfluger T, Melzer H, Mueller W et al (2012) Diagnostic value of combined 18F-FDG PET/MRI for staging and restaging in paediatric oncology Eur J Nucl Med Mol Imaging 39:1745–1755

  19. Krishnasetty V, Bonab AA, Fischman AJ et al (2008) Comparison of standard-dose vs low-dose attenuation correction CT on image quality and positron emission tomographic attenuation correction. J Am Coll Radiol 5:579–584

  20. Cheson BD (2011) Role of functional imaging in the management of lymphoma. J Clin Oncol 29:1844–1854

  21. Abramson SJ, Price AP (2008) Imaging of pediatric lymphomas. Radiol Clin North Am 46:313–338, ix

    Article  PubMed  Google Scholar 

  22. Friedman DL, Chen L, Wolden S et al (2014) Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031. J Clin Oncol 32:3651–3658

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zhu D, Xu XL, Fang C et al (2015) Prognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis. Int J Clin Exp Med 8:15340–15350

    PubMed  PubMed Central  Google Scholar 

  24. Kaste SC, Shulkin BL (2006) 18F-Fluorodeoxyglucose PET/CT in Childhood Lymphoma. PET Clin 1:265–273

    Article  PubMed  Google Scholar 

  25. Jhanwar YS, Straus DJ (2006) The role of PET in lymphoma. J Nucl Med 47:1326–1334

    PubMed  Google Scholar 

  26. Zinzani PL, Stefoni V, Tani M et al (2009) Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 27:1781–1787

    Article  PubMed  Google Scholar 

  27. Jerusalem G, Beguin Y, Fassotte MF et al (2003) Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Ann Oncol 14:123–130

    Article  CAS  PubMed  Google Scholar 

  28. Cashen AF, Dehdashti F, Luo J et al (2011) 18F-FDG PET/CT for early response assessment in diffuse large B-cell lymphoma: poor predictive value of international harmonization project interpretation. J Nucl Med 52:386–392

    Article  PubMed  PubMed Central  Google Scholar 

  29. Truong Q, Shah N, Knestrick M et al (2014) Limited utility of surveillance imaging for detecting disease relapse in patients with non-Hodgkin lymphoma in first complete remission. Clin Lymphoma Myeloma Leuk 14:50–55

    Article  PubMed  Google Scholar 

  30. Thompson CA, Ghesquieres H, Maurer MJ et al (2014) Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol 32:3506–3512

    Article  PubMed  PubMed Central  Google Scholar 

  31. Mengiardi B, Honegger H, Hodler J et al (2005) Primary lymphoma of bone: MRI and CT characteristics during and after successful treatment. AJR Am J Roentgenol 184:185–192

    Article  PubMed  Google Scholar 

  32. Eissa HM, Allen CE, Kamdar K et al (2014) Pediatric Burkitt's lymphoma and diffuse B-cell lymphoma: are surveillance scans required? Pediatr Hematol Oncol 31:253–257

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We would like to thank Dr. Nancy Chauvin at Children's Hospital of Philadelphia for her comments that greatly improved the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kathryn S. Milks.

Ethics declarations

Conflicts of interest

None

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Milks, K.S., McLean, T.W. & Anthony, E.Y. Imaging of primary pediatric lymphoma of bone. Pediatr Radiol 46, 1150–1157 (2016). https://doi.org/10.1007/s00247-016-3597-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00247-016-3597-8

Keywords

Navigation